Corgenix Medical Corp., a developer and marketer of diagnostic test kits, has entered into a contract manufacturing agreement with EDP Biotech to manufacture and supply the ColoMarker diagnostic test, a blood test developed to detect the early stages of colon cancer. Corgenix recently expanded its contract services business unit.
“We are pleased to enter into this mutually beneficial relationship with EDP,” said Douglass Simpson, president and chief executive officer of Corgenix. “This reflects our strategic focus on the Contract Services portion of our business for diagnostic products, and it meets the increasing demand overall for contract services in the medical device and biotechnology industries.”
Corgenix, EDP Biotech In Diagnostic Test Pact
Published July 12, 2013
blog comments powered by Disqus